Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIVARAD study
PACTR202110633346282Phase 1Completed
- Sponsor
- Hedi Chaker Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rivaroxaban in Radial artery occlusion (RAO) (2 arms), sponsored by Hedi Chaker Hospital. Started Nov 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on PACTR202110633346282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202110633346282.